Aurora Innovation
AUR
5.72
-0.03
-0.52%
Aurora Innovation
US · AUR
#1364 by market cap
Listed 1970
5.72
-0.03
-0.52%
Live - 5344 symbols - heartbeat 337s ago
· 2026-10-08 07:39
Pre-market
5.66
-1.05%
After-hours
5.69
-0.61%
Overnight
5.67
-0.87%
- Market cap
- 11.46B
- P/E (TTM)i
- -12.43
- P/Bi
- 5.87
- EPSi
- -0.44
- Div yieldi
- 0.00%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on AUR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 30.14, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Margins
- Gross margin
- -466.67%
- Operating margin
- -30,033.33%
- Net margin
- -27,200.00%
Key ratios & quality
- Altman Z-Scorei
- 30.14
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 19.60M | 0 | 82.00M | 68.00M | 0 | 0 | 3.00M |
| Gross profit | 19.44M | 0 | -- | -- | 0 | 0 | -14.00M |
| Selling & admin expenses | 25.59M | 38.69M | 116.00M | 129.00M | 119.00M | 110.00M | 142.00M |
| Research & development | 107.37M | 179.43M | 697.00M | 677.00M | 716.00M | 676.00M | 745.00M |
| Operating profit | -113.52M | -218.12M | -731.00M | -738.00M | -835.00M | -786.00M | -901.00M |
| Pretax profit | -101.85M | -214.45M | -760.00M | -1.72B | -796.00M | -748.00M | -816.00M |
| Tax | -7.77M | 2.00K | -5.00M | 0 | 0 | 0 | 0 |
| Net profit | -94.08M | -214.45M | -755.00M | -1.72B | -796.00M | -748.00M | -816.00M |
| Basic EPS | 0 | 0 | -1 | -2 | -1 | 0 | 0 |
| Diluted EPS | -0.08 | -0.19 | -1.22 | -1.51 | -0.60 | -0.46 | -0.44 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 1.00M | 1.00M | 1.00M | 1.00M | 2.00M |
| Gross profit | 0 | -4.00M | -5.00M | -5.00M | -5.00M | -5.00M |
| Selling & admin expenses | 29.00M | 36.00M | 38.00M | 39.00M | 44.00M | 50.00M |
| Research & development | 182.00M | 190.00M | 179.00M | 194.00M | 195.00M | 211.00M |
| Operating profit | -211.00M | -230.00M | -222.00M | -238.00M | -244.00M | -266.00M |
| Pretax profit | -208.00M | -201.00M | -201.00M | -206.00M | -223.00M | -270.00M |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net profit | -208.00M | -201.00M | -201.00M | -206.00M | -223.00M | -270.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -0.12 | -0.11 | -0.11 | -0.10 | -0.11 | -0.14 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | -- | 406.45M | 1.68B | 1.12B | 1.22B | 1.25B | 1.32B |
| Cash & ST investments | -- | 387.35M | 1.61B | 1.10B | 1.20B | 1.22B | 1.28B |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | -- | 618.89M | 3.69B | 2.00B | 2.24B | 2.14B | 2.34B |
| Total current liabilities | -- | 31.95M | 91.00M | 83.00M | 111.00M | 105.00M | 111.00M |
| Short-term debt | -- | 6.68M | 12.00M | 13.00M | 15.00M | 16.00M | 11.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- | -- |
| Total liabilities | -- | 895,464,000.00 | 348,000,000.00 | 217,000,000.00 | 250,000,000.00 | 263,000,000.00 | 203,000,000.00 |
| Total equity | -- | -276.58M | 3.34B | 1.78B | 1.99B | 1.88B | 2.14B |
| Retained earnings | -- | -335.76M | -1.09B | -2.81B | -3.61B | -4.36B | -5.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.19B | 1.34B | 1.28B | 1.32B | 1.27B | 1.25B |
| Cash & ST investments | 1.16B | 1.31B | 1.25B | 1.28B | 1.23B | 1.22B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.07B | 2.21B | 2.51B | 2.34B | 2.19B | 2.17B |
| Total current liabilities | 125.00M | 79.00M | 84.00M | 111.00M | 134.00M | 110.00M |
| Short-term debt | 16.00M | 13.00M | 12.00M | 11.00M | 12.00M | 12.00M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 286,000,000.00 | 223,000,000.00 | 219,000,000.00 | 203,000,000.00 | 221,000,000.00 | 214,000,000.00 |
| Total equity | 1.79B | 1.99B | 2.29B | 2.14B | 1.96B | 1.95B |
| Retained earnings | -4.57B | -4.77B | -4.97B | -5.17B | -5.40B | -5.67B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -94.73M | -191.88M | -564.00M | -508.00M | -598.00M | -611.00M | -581.00M |
| Depreciation & amortization | 1.84M | 3.12M | 16.00M | 22.00M | 21.00M | 21.00M | 30.00M |
| Free cash flow | -98.55M | -198.57M | -612.00M | -523.00M | -613.00M | -645.00M | -612.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 318.00K | 2.66M | 8.00M | 13.00M | 840.00M | 497.00M | 916.00M |
| Ending cash balance | 246.97M | 399.83M | 1.63B | 277.00M | 518.00M | 227.00M | 235.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -142.00M | -144.00M | -149.00M | -146.00M | -159.00M | -225.00M |
| Depreciation & amortization | 6.00M | 5.00M | 6.00M | 13.00M | 6.00M | 6.00M |
| Free cash flow | -150.00M | -151.00M | -157.00M | -154.00M | -184.00M | -256.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 85.00M | 342.00M | 469.00M | 20.00M | 21.00M | 226.00M |
| Ending cash balance | 186.00M | 222.00M | 102.00M | 235.00M | 289.00M | 154.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -49.29 | -67.23 | -42.24 | -38.76 | -40.65 |
| ROA %i | -- | -34.65 | -35.06 | -60.55 | -37.58 | -34.21 | -36.42 |
| ROIC %i | -- | -- | -45.60 | -63.71 | -39.53 | -36.46 | -38.67 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- | -47.63 |
| EBIT margin %i | -579.14 | -- | -885.24 | -1,085.29 | -- | -- | -30,033.33 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- | -- |
| Current ratioi | -- | 12.72 | 18.43 | 13.47 | 10.96 | 11.94 | 11.86 |
| Quick ratioi | -- | 12.12 | 17.69 | 13.27 | 10.81 | 11.65 | 11.50 |
| Debt / assetsi | -- | 16.78 | 3.98 | 6.80 | 5.46 | 5.66 | 3.59 |
| LT debt / equityi | -- | -- | 4.04 | 6.89 | 5.39 | 5.60 | 3.41 |
| Interest coveragei | -- | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | 51.38 | 0.00 | -- | -64.67 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -43.43 | -43.68 | -37.27 | -40.65 | -44.33 | -45.64 |
| ROA %i | -38.03 | -39.24 | -33.63 | -36.42 | -39.05 | -41.09 |
| ROIC %i | -40.82 | -41.19 | -35.37 | -38.67 | -42.15 | -43.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -83,600.00 | -43,100.00 | -30,033.33 | -23,350.00 | -19,400.00 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 9.54 | 16.96 | 15.29 | 11.86 | 9.49 | 11.38 |
| Quick ratioi | 9.27 | 16.57 | 14.85 | 11.50 | 9.14 | 11.06 |
| Debt / assetsi | 5.55 | 5.01 | 4.26 | 3.59 | 3.62 | 3.78 |
| LT debt / equityi | 5.55 | 4.92 | 4.15 | 3.41 | 3.41 | 3.58 |
| Interest coveragei | -- | -- | -- | -- | -- | -- |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 07:39:59 · For reference only, not investment advice and not tailored to your situation.